Evidence map›Paper›PMID 35058538›Full record

ArticleScientific reports2022

The major plant sphingolipid long chain base phytosphingosine inhibits growth of bacterial and fungal plant pathogens.

René Glenz, Agnes Kaiping, Delia Göpfert, Hannah Weber, Benjamin Lambour, Marvin Sylvester, Christian Fröschel, Martin J Mueller, Mohamed Osman, Frank Waller

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
6.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Sphingosine synergizes with polymyxin antibiotics againstMicrobiology (Reading, England) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. TheMicrobiology (Reading, England) · 2025
    Article
  7. ThebioRxiv : the preprint server for biology · 2024
    Article
  8. Article
  9. Phytochemical Profiling and Wound Healing Activity ofJournal of experimental pharmacology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Antifungal Peptide P852 Controls Fusarium Wilt in Faba Bean (Antioxidants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

René GlenzJulius-von-Sachs Institute of Biosciences, Pharmaceutical Biology, Julius-Maximilians-Universität Würzburg, Julius-von-Sachs-Platz 2, 97082, Würzburg, Germany.
Agnes KaipingJulius-von-Sachs Institute of Biosciences, Pharmaceutical Biology, Julius-Maximilians-Universität Würzburg, Julius-von-Sachs-Platz 2, 97082, Würzburg, Germany.
Delia GöpfertJulius-von-Sachs Institute of Biosciences, Pharmaceutical Biology, Julius-Maximilians-Universität Würzburg, Julius-von-Sachs-Platz 2, 97082, Würzburg, Germany.
Hannah WeberJulius-von-Sachs Institute of Biosciences, Pharmaceutical Biology, Julius-Maximilians-Universität Würzburg, Julius-von-Sachs-Platz 2, 97082, Würzburg, Germany.
Benjamin LambourJulius-von-Sachs Institute of Biosciences, Pharmaceutical Biology, Julius-Maximilians-Universität Würzburg, Julius-von-Sachs-Platz 2, 97082, Würzburg, Germany.
Marvin SylvesterJulius-von-Sachs Institute of Biosciences, Pharmaceutical Biology, Julius-Maximilians-Universität Würzburg, Julius-von-Sachs-Platz 2, 97082, Würzburg, Germany.
Christian FröschelJulius-von-Sachs Institute of Biosciences, Pharmaceutical Biology, Julius-Maximilians-Universität Würzburg, Julius-von-Sachs-Platz 2, 97082, Würzburg, Germany.
Martin J MuellerJulius-von-Sachs Institute of Biosciences, Pharmaceutical Biology, Julius-Maximilians-Universität Würzburg, Julius-von-Sachs-Platz 2, 97082, Würzburg, Germany.
Mohamed OsmanJulius-von-Sachs Institute of Biosciences, Pharmaceutical Biology, Julius-Maximilians-Universität Würzburg, Julius-von-Sachs-Platz 2, 97082, Würzburg, Germany.
Frank WallerJulius-von-Sachs Institute of Biosciences, Pharmaceutical Biology, Julius-Maximilians-Universität Würzburg, Julius-von-Sachs-Platz 2, 97082, Würzburg, Germany. Frank.Waller@uni-wuerzburg.de.
University of Würzburg · DE

Funding

Deutsche Forschungsgemeinschaft WA 2478/4-1
6 · The paper itself

Abstract

Sphingolipid long chain bases (LCBs) are building blocks of sphingolipids and can serve as signalling molecules, but also have antimicrobial activity and were effective in reducing growth of a range of human pathogens. In plants, LCBs are linked to cell death processes and the regulation of defence reactions against pathogens, but their role in directly influencing growth of plant-interacting microorganisms has received little attention. Therefore, we tested the major plant LCB phytosphingosine in in vitro tests with the plant pathogenic fungi Verticillium longisporum, Fusarium graminearum and Sclerotinia sclerotiorum, the plant symbiotic fungal endophyte Serendipita indica, the bacterial pathogens Pseudomonas syringae pv. tomato (Pst), Agrobacterium tumefaciens, and the related beneficial strain Rhizobium radiobacter. Phytosphingosine inhibited growth of these organisms at micromolar concentrations. Among the fungal pathogens, S. sclerotiorum was the most, and F. graminearum was the least sensitive. 15.9 μg/mL phytosphingosine effectively killed 95% of the three bacterial species. Plant disease symptoms and growth of Pst were also inhibited by phytosphingosine when co-infiltrated into Arabidopsis leaves, with no visible negative effect on host tissue. Taken together, we demonstrate that the plant LCB phytosphingosine inhibits growth of plant-interacting microorganisms. We discuss the potential of elevated LCB levels to enhance plant pathogen resistance.

Indexed as

Agrobacterium tumefaciensAntifungal AgentsArabidopsisFungiGene ExpressionGene Expression Regulation, PlantPlant DiseasesPlant ImmunityPlant LeavesPseudomonas syringaeSphingolipidsSphingosineAntifungal AgentsphytosphingosineSphingolipidsSphingosine

Identifiers

PMID35058538
PMCPMC8776846
OpenAlexW4206275300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.